focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSBS.L Regulatory News (SBS)

  • There is currently no data for SBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Source BioScience plc

14 Sep 2016 16:45

RNS Number : 8700J
Source BioScience PLC
14 September 2016
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Mr Laurie Turnbull (Chairman of Source BioScience plc)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Source BioScience plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Person acting in concert with the offeree

(e) Date dealing undertaken:

13 September 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,048,667

0.8%

nil

-

(2) Cash-settled derivatives:

 

nil

-

nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

nil

-

nil

-

 

TOTAL:

3,048,667

0.8%

nil

-

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Ordinary shares of 2 pence each

 

Details, including nature of the rights concerned and relevant percentages:

 

Director

Maximum number of Ordinary Shares awarded

Date of Grant

First exercisable date

Last exercisable date

Option price (pence)

Laurie Turnbull

500,000

31 Mar 2008

31 Mar 2011

30 mar 2018

7.88p

400,000

26 Apr 2010

26 Apr 2013

25 Apr 2020

8.25p

 

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

n/a

n/a

n/a

n/a

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

n/a

n/a

n/a

n/a

n/a

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

n/a

n/a

n/a

n/a

n/a

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Ordinary shares of 2 pence each

Share options

Exercised

298,667

Nil

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

n/a

n/a

n/a

n/a

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 September 2016

Contact name:

Nick Ash (Company Secretary)

Telephone number:

+44 (0) 115 973 9010

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCAKQDQPBKDDCD
Date   Source Headline
15th Sep 20163:49 pmRNSScheme Effective / Unlisted Securities Alternative
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) - Source BioScience plc
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) - Source BioScience plc
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) Source BioScience plc
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) - Source BioScience plc
14th Sep 20164:45 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 20164:42 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 20164:40 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 20164:38 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 201611:29 amRNSDirector/PDMR Shareholding
13th Sep 20163:23 pmRNSAdditional Listing on Exercise of Share Options
13th Sep 20163:19 pmRNSScheme becomes Effective: Announcement error
13th Sep 20162:25 pmRNSCourt Sanction of the Scheme
13th Sep 20161:00 pmRNSScheme of arrangement becomes Effective
13th Sep 201612:04 pmRNSForm 8.3 - Source BioScience plc
13th Sep 20169:49 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
9th Sep 20164:17 pmRNSResults of Court Meeting and General Meeting
7th Sep 201610:55 amRNSRule 2.10 Announcement
6th Sep 20162:19 pmRNSForm 8.5 (EPT/RI) - Source Bioscience
6th Sep 201612:03 pmRNSAdditional Listing
6th Sep 201610:27 amRNSForm 8.5 (EPT/RI) - Source Bioscience
5th Sep 201610:11 amRNSForm 8.3 - Source BioScience plc
2nd Sep 201612:09 pmRNSForm 8.3 - Source BioScience plc
1st Sep 20161:20 pmRNSForm 8.3 - Source BioScience plc
31st Aug 201611:44 amRNSForm 8.3 - Source BioScience plc
30th Aug 20161:18 pmRNSForm 8.3 - Source BioScience plc
26th Aug 201612:57 pmRNSForm 8.3 - Source BioScience plc
26th Aug 20169:38 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
25th Aug 20162:30 pmRNSForm 8.3 - Source BioScience plc - Amendment
25th Aug 20169:44 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
24th Aug 201611:59 amRNSForm 8.3 - Source BioScience plc
24th Aug 20169:40 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
23rd Aug 20169:56 amRNSForm 8.5 (EPT/RI) - Source Bioscience
19th Aug 201610:19 amRNSForm 8.3 - Source BioScience plc
19th Aug 20169:53 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
18th Aug 20162:35 pmRNSForm 8.3 - Source BioScience plc
18th Aug 20167:00 amRNSPosting of Scheme Document
17th Aug 201610:49 amRNSForm 8.3 - Source BioScience plc
16th Aug 20162:10 pmRNSForm 8.3 - Source BioScience plc
15th Aug 20161:52 pmRNSForm 8.3 - Source BioScience plc
12th Aug 20169:33 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
12th Aug 20167:00 amRNSForm 8.3 - Source BioScience plc
11th Aug 20162:14 pmRNSForm 8.3 - Source BioScience plc
11th Aug 20169:24 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
10th Aug 20169:22 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
9th Aug 20164:02 pmRNSForm 8.3 - Source BioScience plc
9th Aug 20169:21 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
8th Aug 20162:14 pmRNSForm 8.3 - Source BioScience plc
8th Aug 20169:36 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
5th Aug 20161:56 pmRNSForm 8.3 - Source BioScience plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.